![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1454021
¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ¼ÒºñÀÚ ¿þ¾î·¯ºí, ±â¼ú, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®Vital Signs Monitoring Systems Market Forecasts to 2030 - Global Analysis By Product Type, Type, Consumer Wearables, Technology, Application, End User and By Geography |
Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 101¾ï ´Þ·¯¸¦ Â÷ÁöÇÏ°í ¿¹Ãø ±â°£ Áß CAGR 10.5%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 204¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.
¹ÙÀÌÅ» »çÀÎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº Áß¿äÇÑ »ý¸®Àû ¸Å°³ º¯¼ö¸¦ ÃßÀûÇÏ°í °Ç° ÀÌ»óÀ» Àû½Ã¿¡ °¨ÁöÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÈ ÷´Ü ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ½É¹Ú¼ö, Ç÷¾Ð, È£Èí¼ö, ü¿Â µîÀÇ ÁöÇ¥¸¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ÃÖ÷´Ü ¼¾¼ ±â¼úÀ» Ȱ¿ëÇÏ¿© ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á Àü¹®°¡°¡ ȯÀÚÀÇ »óÅ º¯È¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÈÞ´ë°¡ °£ÆíÇÏ°í »ç¿ëÀÚ Ä£ÈÀûÀÎ ÀÌ ½Ã½ºÅÛÀº ¿ø°Ý ¸ð´ÏÅ͸µ°ú Á¶±â °³ÀÔÀ» ¿ëÀÌÇÏ°Ô ÇÔÀ¸·Î½á ȯÀÚ Ä¡·á¸¦ °³¼±ÇÕ´Ï´Ù.
Global Health ObservatoryÀÇ µ¥ÀÌÅÍ¿¡ µû¸£¸é 2019³â »ç¸ÁÀÚÀÇ 71%°¡ ºñ°¨¿°¼º Áúȯ(NCDs)À¸·Î ÀÎÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ÁÖ¿ä NCD´Â ½ÉÇ÷°ü Áúȯ(CVD)ÀÌ Àüü NCD »ç¸ÁÀÚÀÇ 45.0%, ¾ÏÀÌ Àüü NCD »ç¸ÁÀÚÀÇ 22.0%, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)ÀÌ Àüü NCD »ç¸ÁÀÚÀÇ 10.0%, ´ç´¢º´ÀÌ Àüü NCD »ç¸ÁÀÚÀÇ 4.0%¸¦ Â÷ÁöÇÕ´Ï´Ù.
¸¸¼ºÁúȯ Áõ°¡
°íÇ÷¾Ð, ´ç´¢º´, ½ÉÇ÷°ü Áúȯ°ú °°Àº Áúº´ÀÌ ¸¸¿¬ÇÔ¿¡ µû¶ó Áö¼ÓÀûÀÎ °Ç° ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ȱ·Â¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº Áß¿äÇÑ ¸Å°³º¯¼ö¿¡ ´ëÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© ¸¸¼ºÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ°í °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ´Â ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÀÌ ½ÃÀå¿¡¼´Â »ç¿ëÀÚ Ä£ÈÀûÀÎ ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ±â¼ú Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼ ȯÀÚ ¹× ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õ Áõ°¡ÇÏ´Â ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â Á¾ÇÕÀûÀÎ °Ç° ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ¿ªµ¿ÀûÀÎ Àü¸Á¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.
³ôÀº Ãʱ⠺ñ¿ë°ú Áö¼ÓÀûÀÎ ºñ¿ë
ÀÇ·á ±â°üÀº ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼ ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ÅõÀÚÇÏ´Â °ÍÀ» ÁÖÀúÇÒ ¼ö ÀÖ½À´Ï´Ù. °æÁ¦Àû ºÎ´ãÀº º¸±ÞÀ» Á¦ÇÑÇϰí ÀÇ·á ÇÁ·Î¹ÙÀÌ´õ¿Í ȯÀÚ ¸ðµÎ¿¡°Ô Á¢±Ù¼ºÀ» ÀúÇØÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àå¾Ö¹°Àº ÷´Ü ¸ð´ÏÅ͸µ ±â¼úÀÌ ÁÖ·ù ÀÇ·á¿¡ ÅëÇյǴ °ÍÀ» Áö¿¬½Ã۰í, Áö¼ÓÀûÀÎ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ ÀáÀçÀû ÀÌÁ¡À» ÀúÇØÇÕ´Ï´Ù.
ÀçÅÃÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
°³°³ÀÎÀÌ º¸´Ù Æí¸®ÇÏ°í °³ÀÎÈµÈ °Ç°°ü¸® ¼Ö·ç¼ÇÀ» ¿øÇÔ¿¡ µû¶ó Áý¿¡¼ »ýü½ÅÈ£¸¦ ¸ð´ÏÅ͸µÇÏ´Â °ÍÀ» ¼±È£ÇÏ´Â °æÇâÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Ȱ·Â¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀº Áö¼ÓÀûÀÎ °Ç° ÃßÀûÀ» °¡´ÉÇÏ°Ô ÇÏ´Â »ç¿ëÀÚ Ä£ÈÀûÀÎ ÈÞ´ë¿ë ±â±â¸¦ Á¦°øÇÔÀ¸·Î½á ÀÌ·¯ÇÑ ¼ö¿ä¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡¼´Â ¿þ¾î·¯ºí ¸ð´ÏÅ͸µ Àåºñ ¹× ¿ø°ÝÀÇ·á ÅëÇÕ°ú °°Àº Çõ½ÅÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ¿ø°Ý ȯÀÚ Ä¡·á¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. °í·ÉÈ ¹× COVID-19 ÆÒµ¥¹Í°ú °°Àº ¿äÀÎÀ¸·Î ÀÎÇØ °¡¼Óȵǰí ÀÖ´Â ÀçÅÃÄ¡·á·ÎÀÇ ÀüȯÀÌ ½ÃÀå È®´ë¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ´Éµ¿ÀûÀ̰í Á¢±Ù¼ºÀÌ ³ôÀº °Ç° ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ È¯ÀÚµéÀÇ ÁøÈÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù.
µ¥ÀÌÅÍ ÀúÀå¿¡ ÀÖÀ¸¸ç, µðÁöÅÐ Ç÷§Æû¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡
»çÀ̹ö º¸¾È À§ÇùÀº ȯÀÚÀÇ ±â¹Ð Á¤º¸¸¦ À§Çè¿¡ ºü¶ß¸± ¼ö ÀÖ´Â ½É°¢ÇÑ À§ÇèÀÔ´Ï´Ù. ÀÌ ¶§¹®¿¡ ÀÇ·áÁø°ú ȯÀÚµé »çÀÌ¿¡¼ ÀúÇ×°¨ÀÌ Ä¿Á® º¸±Þ¿¡ °É¸²µ¹ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹«´Ü Á¢±Ù°ú µ¥ÀÌÅÍ À¯Ãâ¿¡ ´ëÇÑ µÎ·Á¿òÀ¸·Î ÀÎÇØ ÷´Ü ¸ð´ÏÅ͸µ ±â¼úÀÇ ÀÇ·á ÇöÀå µµÀÔÀÌ ´õµð°Ô ÁøÇàµÉ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼ µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ½Å·Ú¸¦ ±¸ÃàÇϰí, ȯÀÚ µ¥ÀÌÅÍÀÇ ¾ÈÀüÇϰí À±¸®ÀûÀÎ »ç¿ëÀ» º¸ÀåÇϸç, ½ÃÀåÀÇ Áö¼ÓÀûÀÎ ¼ºÀåÀ» °¡¼ÓÇϱâ À§Çؼ´Â ÀÌ·¯ÇÑ º¸¾È ¹®Á¦¸¦ ÇØ°áÇÏ°í ¿ÏÈÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù.
COVID-19ÀÇ ¿µÇâ
¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ°ú ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÇ·á ¼ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº COVID-19 ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î ¸ð´ÏÅ͸µÇϱâ À§ÇØ ÀÌ·¯ÇÑ ½Ã½ºÅÛÀ» Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ·¯½º °¨¿°À» ÃÖ¼ÒÈÇϱâ À§ÇØ ºñÁ¢ÃË½Ä È°·Â ¡ÈÄ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÆÒµ¥¹ÍÀº Á¶±â ¹ß°ß°ú Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀÇ Á߿伺À» °Á¶Çϸç ÷´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ÁøÈÇÏ´Â ÀÇ·á ȯ°æ¿¡ ´ëÀÀÇϱâ À§ÇØ ±â¼ú Çõ½Å°ú Çù¾÷ Áõ°¡¸¦ ¸ñ°ÝÇϰí ÀÖÀ¸¸ç, ÇöÀç ÁøÇà ÁßÀÎ ¼¼°è º¸°Ç À§±â¿¡¼ ȯÀÚ Ä¡·á¸¦ °ÈÇϰí ÀÇ·áÁøÀ» Áö¿øÇϴ Ȱ·Â¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ¿ªÇÒÀÌ °Á¶µÇ°í ÀÖ½À´Ï´Ù.
¿¹Ãø ±â°£ Áß Ç÷¾Ð ¸ð´ÏÅÍ ºÎ¹®ÀÌ °¡Àå Ŭ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
°íÇ÷¾Ð ¹× ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â °¡Á¤¿ë Ç÷¾Ð ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí Á¾ÇÕÀûÀΠȰ·Â ¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ º´Çà »ó½ÂÀ» ÃËÁøÇϱ⠶§¹®¿¡ Ç÷¾Ð ¸ð´ÏÅÍ ºÎ¹®Àº À¯¸®ÇÑ ¼ºÀåÀ» ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ Ç÷¾Ð ¸ð´ÏÅ͸µÀÌ °íµµ·Î ÅëÇÕµÇ¸é¼ Áø´Ü ±â´ÉÀÌ °ÈµÇ¾î ÀÇ·á Àü¹®°¡¿Í ¼ÒºñÀÚ ¸ðµÎ¸¦ ¸Å·á½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú ¹ßÀü°ú ½ÃÀå °æÀïÀÇ È®´ë¿¡ µû¸¥ ±â¼ú Çõ½ÅÀº º¸´Ù Á¤È®ÇÏ°í »ç¿ëÀÚ Ä£ÈÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.
¿¹Ãø ±â°£ Áß ¿Ü·¡ Ç÷¾Ð ¸ð´ÏÅÍ ºÐ¾ß°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¿Ü·¡ ȯÀÚ Ç÷¾Ð ¸ð´ÏÅÍ ºÐ¾ß´Â ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Áö¼ÓÀûÀÎ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±âÀÎÇϸç, ¿Ü·¡ ȯÀÚ Ç÷¾Ð ¸ð´ÏÅÍ´Â ÀÓ»ó ȯ°æ ¹Û¿¡¼ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â µ¥ ÀÖÀ¸¸ç, ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¾ÇÕÀûÀÎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀ» ÅëÇØ ½ÃÀå ¹üÀ§°¡ È®´ëµÇ°í º¸´Ù Á¾ÇÕÀûÀÎ °Ç° Æò°¡°¡ °¡´ÉÇØÁý´Ï´Ù. ¿Ü·¡¿ë ¸ð´ÏÅÍ´Â ¿ªµ¿ÀûÀÎ ½ÃÀå »óȲ¿¡ ±â¿©Çϰí, Æí¸®Çϰí Áö¼ÓÀûÀΠȰ·Â ¡Èĸ¦ ÃßÀûÇϰíÀÚ ÇÏ´Â ÀÇ·á Àü¹®°¡¿Í ȯÀÚÀÇ ÁøÈÇÏ´Â ¼±È£µµ¸¦ ÃæÁ·½ÃÄÑ ±Ã±ØÀûÀ¸·Î ±¤¹üÀ§ÇÑ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå¿¡¼ Çõ½Å°ú °æÀïÀ» ÃËÁøÇÕ´Ï´Ù.
¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ Áß °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁÖ¿ä ÀÌÀ¯´Â ³ëÀÎ Àα¸ Áõ°¡, Áö¼Ó¼º Áúȯ Áõ°¡, ¿ø°Ý ¹× ¹«¼± ±â±â¿¡ ´ëÇÑ °ü½É Áõ°¡, º¸Çè Àû¿ë Á¤Ã¥ÀÇ °£¼ÒÈ µîÀÌ ÀÖ½À´Ï´Ù. À̴ ƯÈ÷ Àεµ¿Í Áß±¹ µî ½ÅÈï ±¹°¡ ½ÃÀå¿¡¼ 1Â÷ ÀǷḦ Æ÷ÇÔÇÑ ÀÌ Áö¿ªÀÇ ±¤¹üÀ§ÇÑ ¹ÌÃæÁ· ¼ö¿ä¿¡ ±âÀÎÇÕ´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ªÀÇ ÀÇ·á °ü±¤ÀÇ ºÎ»ó°ú ÀÇ·á ºÎ¹®ÀÇ °³¼±Àº ¿¹Ãø ±â°£ Áß ½ÃÀå ±â¾÷¿¡°Ô ¸¹Àº °ÍÀ» Á¦°øÇÕ´Ï´Ù.
ºÏ¹Ì´Â Àα¸°¡ ¸¹°í °¡Ã³ºÐ ¼ÒµæÀÌ ³ôÀ¸¸ç, ÷´Ü ¸ð´ÏÅ͸µ Àåºñ¿¡ ´ëÇÑ È¯ÀÚ ÀνÄÀÌ °³¼±µÇ°í, ¸»¶ó¸®¾Æ ¹× ÀåÆ¼Çª½º¿Í °°Àº °¨¿°¼º ÁúȯÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ Áß °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ ³ëÀÎ Àα¸ Áõ°¡¿Í ÀçÅà °£È£ ȯ°æ¿¡¼ Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â Ȱ·Â ¡ÈÄ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ Áö¿ªÀº Çʼö ÀÇ·á±â±â¿¡ ´ëÇÑ »óȯ Á¦µµ°¡ Àß °®Ãß¾îÁ® ÀÖÀ¸¸ç, ÀÇ·á ¼ºñ½º¿¡ ´ëÇÑ Àνİú Á¢±Ù¼ºÀÌ ³ô¾Æ ¼ö¿ä°¡ ³ôÀº °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù.
According to Stratistics MRC, the Global Vital Signs Monitoring Systems Market is accounted for $10.1 billion in 2023 and is expected to reach $20.4 billion by 2030 growing at a CAGR of 10.5% during the forecast period. Vital Signs Monitoring Systems are advanced medical devices designed to track crucial physiological parameters, ensuring timely detection of health abnormalities. These systems continuously monitor indicators such as heart rate, blood pressure, respiratory rate, and body temperature. Utilizing cutting-edge sensor technology, they provide real-time data, enabling healthcare professionals to promptly respond to fluctuations in a patient's condition. Portable and user-friendly, these systems enhance patient care by facilitating remote monitoring and early intervention.
According to the Global Health Observatory data, in 2019, 71% of the deaths were due to Non-Communicable Diseases (NCDs). The major NCDs are Cardiovascular Diseases (CVDs), which caused 45.0% of all NCD deaths, cancer caused 22.0% of all NCD deaths, and Chronic Obstructive Pulmonary Disease (COPD) caused 10.0% of all NCD deaths, and diabetes caused 4.0% of all NCD deaths.
Increasing prevalence of chronic diseases
As conditions like hypertension, diabetes, and cardiovascular diseases become more prevalent, the demand for continuous health monitoring escalates. Vital Signs Monitoring Systems play a pivotal role by providing real-time data on crucial parameters, aiding in early detection and management of chronic conditions. The market experiences a surge in demand for user-friendly, remote monitoring solutions, fostering innovation in technology. With an increasing emphasis on preventive healthcare, the market expands to address the growing needs of patients and healthcare providers, contributing to the dynamic landscape of comprehensive health monitoring systems.
High initial costs and ongoing expenses
Healthcare institutions may hesitate to invest in these systems, especially in resource-limited environments. The financial burden limits widespread adoption, hindering accessibility for both providers and patients. This obstacle slows the integration of advanced monitoring technologies into mainstream healthcare practices, impeding the potential benefits of continuous, remote patient monitoring.
Growing demand for home-based healthcare
Individuals seek more convenient and personalized healthcare solutions, there is an increasing preference for monitoring vital signs at home. Vital Signs Monitoring Systems cater to this demand by offering user-friendly, portable devices that enable continuous health tracking. The market experiences a surge in innovations such as wearable monitoring devices and telehealth integrations, facilitating remote patient care. The shift towards home-based healthcare, accelerated by factors like aging populations and the COVID-19 pandemic, propels the market's expansion, meeting the evolving needs of patients for proactive and accessible health monitoring solutions.
Increasing reliance on digital platforms for data storage
Cybersecurity threats pose a significant risk, potentially compromising sensitive patient information. This raises reluctance among healthcare providers and patients, hindering widespread adoption. Fear of unauthorized access and data breaches may impede the integration of advanced monitoring technologies into mainstream healthcare practices. Thus, addressing and mitigating these security challenges are vital to building trust in digital healthcare solutions, ensuring the safe and ethical use of patient data, and fostering the sustained growth of the market.
Covid-19 Impact
With a heightened focus on remote patient monitoring and telehealth, healthcare providers increasingly utilize these systems to monitor COVID-19 patients remotely. The demand for non-contact vital signs monitoring solutions has surged to minimize virus transmission. Additionally, the pandemic has underscored the importance of early detection and continuous monitoring, driving investments in advanced technologies. The market has witnessed increased innovation and collaboration to meet the evolving healthcare landscape, emphasizing the role of Vital Signs Monitoring Systems in enhancing patient care and supporting healthcare professionals during the ongoing global health crisis.
The blood pressure monitors segment is expected to be the largest during the forecast period
The blood pressure monitors segment is estimated to have a lucrative growth, due to increasing prevalence of hypertension and cardiovascular diseases drives the demand for at-home blood pressure monitoring devices, fostering a parallel rise in comprehensive vital signs monitoring systems. Advanced integration of blood pressure monitoring into these systems enhances their diagnostic capabilities, attracting both healthcare professionals and consumers. Further the market experiences innovation and competitive expansion as technology evolves, offering more accurate and user-friendly solutions.
The ambulatory blood pressure monitors segment is expected to have the highest CAGR during the forecast period
The ambulatory blood pressure monitors segment is anticipated to witness the highest CAGR growth during the forecast period, owing to the demand for continuous and remote patient monitoring, ambulatory blood pressure monitors play a pivotal role in providing real-time data outside clinical settings. Their integration into comprehensive monitoring systems expands the market's scope, enabling a more holistic health assessment. Ambulatory monitors contribute to a dynamic market landscape, addressing the evolving preferences of healthcare professionals and patients for convenient and continuous vital signs tracking, ultimately fostering innovation and competitiveness within the broader monitoring systems market.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the growing geriatric population, rising occurrences of interminable disorders, and developing interest in remote and wireless devices combined with streamlined coverage policies are the main considerations credited to its share. This can be attributed to the extensive unmet needs in this region including primary healthcare, especially in developing markets, such as India and China. Moreover, the rising medical tourism and improving healthcare sectors in this region have a lot to offer the market players over the forecast period.
North America is projected to have the highest CAGR over the forecast period, owing to owing to its high population base, high disposable incomes, improvement in patient awareness about advanced monitoring devices, and increase in incidences of infectious diseases such as malaria and typhoid. Moreover, rise in geriatric population and increase in demand for vital signs monitoring devices for home care settings have contributed to the vital signs monitoring devices market growth. Thus the region also has high awareness and access to healthcare services with strong reimbursement coverage for essential medical devices, thereby leading to high demand.
Key players in the market
Some of the key players in the Vital Signs Monitoring Systems Market include CONTEC Medical Systems Co., Ltd., Criticare Systems, Inc., General Electric Company, Infinium Medical, Masimo Corporation, Medtronic plc, Mindray Medical International Limited, Natus Medical Incorporated, Nihon Kohden Corporation, Nonin Medical, Inc., Omron Healthcare, Philips Healthcare, Progetti srl, Rapid Response Monitoring, Schiller AG, Smiths Medical, Spacelabs Healthcare, SunTech Medical and Welch Allyn
In February 2024, Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth. The collaboration is designed to leverage the unique capabilities of both organizations and pursue their mutual goals of improving patient outcomes, reducing the cost of care, and transforming models of care delivery across the continuum
In January 2024, Medtronic Diabetes announces world's first approval for MiniMed(TM) 780G Systems with Simplera Sync(TM) disposable, all-in-one sensor. The MiniMed 780G system with Simplera Sync(TM) sensor will be available in Europe via limited release in spring 2024.
In January 2024, Mindray Unveils UX Series Endoscope Camera System, Empowering Surgical Precision with Innovative Technology. By integrating a new generation hardware platform with advanced software algorithms, the UX Series sets a new standard for image performance and potential for future expandability.